Suppr超能文献

[肺癌发生发展中遗传多样性选择的假说:分子进化与临床意义]

[Hypothesis of Genetic Diversity Selection in the Occurrence and Development of 
Lung Cancer: Molecular Evolution and Clinical Significance].

作者信息

Liu Baodong

机构信息

Department of Thoracic Surgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.

出版信息

Zhongguo Fei Ai Za Zhi. 2024 Jan 2;26(12):943-949. doi: 10.3779/j.issn.1009-3419.2023.101.34.

Abstract

So far, the monoclonal hypothesis of tumor occurrence and development cannot be justified. The genetic diversity selection hypothesis for the occurrence and development of lung cancer links Mendelian genetics with Darwin's theory of evolution, suggesting that the genetic diversity of tumor cell populations with polyclonal origins-monoclonal selection-subclonal expansion is the result of selection pressure. Normal cells acquire mutations in oncogenic driver genes and have a selective advantage over other cells, becoming tumor initiating cells; In the interaction with the tumor microenvironment (TME), the vast majority of initiating cells are recognized and killed by the human immune system. If immune escape occurs, the incidence of malignant tumors will greatly increase, and subclonal expansion, intratumour heterogeneity, etc. will occur. This article proposed the hypothesis of genetic diversity selection and analyzed its clinical significance.
.

摘要

到目前为止,肿瘤发生发展的单克隆假说尚无法得到证实。肺癌发生发展的遗传多样性选择假说将孟德尔遗传学与达尔文进化论联系起来,表明具有多克隆起源的肿瘤细胞群体的遗传多样性——单克隆选择——亚克隆扩增是选择压力的结果。正常细胞在致癌驱动基因中获得突变,并比其他细胞具有选择性优势,成为肿瘤起始细胞;在与肿瘤微环境(TME)的相互作用中,绝大多数起始细胞被人体免疫系统识别并杀死。如果发生免疫逃逸,恶性肿瘤的发病率将大大增加,并会出现亚克隆扩增、肿瘤内异质性等情况。本文提出了遗传多样性选择假说并分析了其临床意义。

相似文献

3
Genomic Landscape and Immune Microenvironment Features of Preinvasive and Early Invasive Lung Adenocarcinoma.
J Thorac Oncol. 2019 Nov;14(11):1912-1923. doi: 10.1016/j.jtho.2019.07.031. Epub 2019 Aug 22.
7
Extensive subclonal mutational diversity in human colorectal cancer and its significance.
Proc Natl Acad Sci U S A. 2019 Dec 26;116(52):26863-26872. doi: 10.1073/pnas.1910301116. Epub 2019 Dec 5.
9
10
Tumor Evolution, Heterogeneity, and Therapy for Our Patients With Advanced Cancer: How Far Have We Come?
Am Soc Clin Oncol Educ Book. 2017;37:e8-e15. doi: 10.1200/EDBK_175524.

本文引用的文献

1
Individualized tumor-informed circulating tumor DNA analysis for postoperative monitoring of non-small cell lung cancer.
Cancer Cell. 2023 Oct 9;41(10):1749-1762.e6. doi: 10.1016/j.ccell.2023.08.010. Epub 2023 Sep 7.
2
The global burden of lung cancer: current status and future trends.
Nat Rev Clin Oncol. 2023 Sep;20(9):624-639. doi: 10.1038/s41571-023-00798-3. Epub 2023 Jul 21.
3
Distinct immune microenvironment of lung adenocarcinoma in never-smokers from smokers.
Cell Rep Med. 2023 Jun 20;4(6):101078. doi: 10.1016/j.xcrm.2023.101078. Epub 2023 Jun 9.
4
Hallmarks of transcriptional intratumour heterogeneity across a thousand tumours.
Nature. 2023 Jun;618(7965):598-606. doi: 10.1038/s41586-023-06130-4. Epub 2023 May 31.
5
Pan-cancer whole-genome comparison of primary and metastatic solid tumours.
Nature. 2023 Jun;618(7964):333-341. doi: 10.1038/s41586-023-06054-z. Epub 2023 May 10.
6
Genomic mapping of metastatic organotropism in lung adenocarcinoma.
Cancer Cell. 2023 May 8;41(5):970-985.e3. doi: 10.1016/j.ccell.2023.03.018. Epub 2023 Apr 20.
7
The evolution of non-small cell lung cancer metastases in TRACERx.
Nature. 2023 Apr;616(7957):534-542. doi: 10.1038/s41586-023-05729-x. Epub 2023 Apr 12.
8
Evolutionary characterization of lung adenocarcinoma morphology in TRACERx.
Nat Med. 2023 Apr;29(4):833-845. doi: 10.1038/s41591-023-02230-w. Epub 2023 Apr 12.
9
Role of the Microbiota in Lung Cancer: Insights on Prevention and Treatment.
Int J Mol Sci. 2022 May 30;23(11):6138. doi: 10.3390/ijms23116138.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验